Proskauer

Barings, Kline Hill Partners, and Adams Street Partners Co-Lead Closing of TRP Capital Partners’ Continuation Fund for GenOx Transportation Inc.

Retrieved on: 
Monday, February 26, 2024

Barings, Kline Hill Partners (“Kline Hill”), and Adams Street Partners (“Adams Street”) today announced that they served as co-lead investors in the completion of a single asset continuation fund in support of TRP Capital Partners (“TRP”), Founder and CEO Kevin Mathews, and the management team of GenOx Transportation Inc. ("GenOx” or “the Company”), a leading industrial gas transportation company.

Key Points: 
  • Barings, Kline Hill Partners (“Kline Hill”), and Adams Street Partners (“Adams Street”) today announced that they served as co-lead investors in the completion of a single asset continuation fund in support of TRP Capital Partners (“TRP”), Founder and CEO Kevin Mathews, and the management team of GenOx Transportation Inc. ("GenOx” or “the Company”), a leading industrial gas transportation company.
  • We are pleased to continue our partnership with Kevin and the management team and welcome the support from our new secondary fund partners and investors,” said David Mitchell, Managing Partner at TRP Capital Partners.
  • We look to continue investing heavily in GenOx’s specialized fleet to support the industry and provide superior service for our customers,” added Michael Vellucci, Partner at TRP Capital Partners.
  • GenOx will continue to operate as a standalone business under the leadership of its existing management team, led by Kevin Mathews.

New Employment Discrimination Deskbook Provides Practical Advice on Managing Workplace Risk

Retrieved on: 
Tuesday, May 23, 2023

A new treatise from Practising Law Institute's PLI Press, Employment Discrimination: A Practitioner's Deskbook , helps employers and their counsel evaluate and address these issues.

Key Points: 
  • A new treatise from Practising Law Institute's PLI Press, Employment Discrimination: A Practitioner's Deskbook , helps employers and their counsel evaluate and address these issues.
  • Authored by Keisha-Ann G. Gray , a seasoned employment litigator and trial counsel, this treatise is a comprehensive resource for employment practitioners and anyone interested in managing workplace risk when confronted with employment discrimination and harassment claims.
  • The Deskbook provides current and practical tips for effectively managing all areas of employment discrimination-related work.
  • To learn more and order a copy of Employment Discrimination: A Practitioner's Deskbook, click here .

Ridgemont Equity Partners Recapitalizes Worldwide Produce

Retrieved on: 
Tuesday, January 24, 2023

Ridgemont Equity Partners , a middle market private equity investor, today announced the recapitalization of Worldwide Produce (the “Company”), a leading distributor of fresh fruits, vegetables, dairy products and specialty foods to restaurants, foodservice customers and grocery stores across the western United States.

Key Points: 
  • Ridgemont Equity Partners , a middle market private equity investor, today announced the recapitalization of Worldwide Produce (the “Company”), a leading distributor of fresh fruits, vegetables, dairy products and specialty foods to restaurants, foodservice customers and grocery stores across the western United States.
  • Sole Source Capital , the Company’s existing financial sponsor, will retain a meaningful minority stake in Worldwide Produce in partnership with Ridgemont and Company management.
  • Harris Williams LLC served as financial advisor to Ridgemont, and Truist Securities served as financial advisor to Worldwide Produce and Sole Source.
  • This investment was made from Ridgemont Equity Partners IV, L.P. Financial terms of the transaction were not disclosed.

Integra LifeSciences Announces Definitive Agreement to Acquire Surgical Innovation Associates (SIA) and Plans for $150 Million Share Repurchase

Retrieved on: 
Thursday, December 1, 2022

PRINCETON, N.J., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (NASDAQ:IART), a leading global medical technology company, today announced that it entered into a definitive agreement to acquire Surgical Innovation Associates (SIA), which develops, markets and sells DuraSorb®, a resorbable synthetic matrix for plastic and reconstructive surgery. This acquisition will advance Integra’s global strategy in breast reconstruction, expanding plans to access the U.S. market with devices specifically approved by the FDA for use in implant-based breast reconstruction (IBBR) procedures. The transaction is expected to close by the end of the year, subject to the satisfaction of customary conditions.

Key Points: 
  • The addition of DuraSorbs resorbable synthetic technology will further strengthen Integras plastic and reconstructive surgery portfolio, which includes SurgiMend PRS , a xenograft surgical matrix.
  • The global breast reconstruction market represents an attractive growth opportunity for our surgical reconstruction business, said Robert T. Davis, Jr., executive vice president and president, Tissue Technologies, Integra LifeSciences.
  • The company is planning a $150 million share repurchase as a part of a previous approval by the board of directors.
  • Surgical Innovation Associates, Inc (SIA) is a Northwestern University spin-out founded in 2016 by Alexei Mlodinow, Todd Cruikshank, and technology inventor Dr. John Kim.

Surgical Innovation Associates (SIA) Announces Definitive Agreement to be Acquired by Integra LifeSciences

Retrieved on: 
Thursday, December 1, 2022

Surgical Innovation Associates (SIA) today announced that it entered into a definitive agreement to be acquired by Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company.

Key Points: 
  • Surgical Innovation Associates (SIA) today announced that it entered into a definitive agreement to be acquired by Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company.
  • The transaction is expected to close by the end of the year, subject to the satisfaction of customary conditions.
  • Today, there are no surgical matrices approved by the FDA specifically for use in implant-based breast reconstruction (IBBR) for mastectomy patients.
  • Integra is the only manufacturer so far to submit a premarket approval (PMA) application for this soft tissue support in IBBR.

Trinity Hunt Announces Successful Closing of $618 Million Continuation Fund for Portfolio Companies Improving and Argano

Retrieved on: 
Friday, October 21, 2022

DALLAS, Oct. 21, 2022 /PRNewswire/ -- Trinity Hunt Partners, a growth-oriented private equity firm, today announced the closing of its first Continuation Fund, raising capital to support the acquisitions of Argano and Improving, two premier technology services companies, from Trinity Hunt Partners V, L.P. The Continuation Fund closed on $618 million in commitments, which includes a substantial pool of capital for follow-on investments to support the continued growth of the companies.

Key Points: 
  • DALLAS, Oct. 21, 2022 /PRNewswire/ -- Trinity Hunt Partners , a growth-oriented private equity firm, today announced the closing of its first Continuation Fund, raising capital to support the acquisitions of Argano and Improving, two premier technology services companies, from Trinity Hunt Partners V, L.P.
  • Trinity Hunt Partners, a growth-oriented private equity firm, announces the closing of its first Continuation Fund.
  • We're excited to build on our partnership with Trinity Hunt in a transaction that will support these two companies in their continued value creation."
  • "The closing of our first continuation fund is an important milestone for Trinity Hunt," said Blake Apel, Managing Partner.

Resurgens Technology Partners Closes its $500 Million Software-Focused Private Equity Fund II

Retrieved on: 
Friday, September 16, 2022

Resurgens Technology Partners, a tech-focused private equity firm, today announced it has completed fundraising for Resurgens Technology Partners II (Fund II) with greater than $500 million in total capital commitments.

Key Points: 
  • Resurgens Technology Partners, a tech-focused private equity firm, today announced it has completed fundraising for Resurgens Technology Partners II (Fund II) with greater than $500 million in total capital commitments.
  • Resurgens is committed to delivering world-class operating support, talent and human capital expertise and M&A execution capabilities to each of its portfolio companies.
  • We are thankful for the support from our existing and new limited partners, said Resurgens Managing Director Fred Sturgis.
  • Resurgens Technology Partners is a tech-focused private equity firm investing in North American and select European lower middle-market application and IT infrastructure software businesses.

Spectrum Equity Closes Fund X at $2 Billion

Retrieved on: 
Wednesday, July 27, 2022

BOSTON, July 27, 2022 (GLOBE NEWSWIRE) -- Spectrum Equity , a leading growth equity firm, today announced the closing of Spectrum Equity X, L.P. ("Fund X") at a hard cap of $2 billion.Fund X was oversubscribed, receiving strong support from long-standing limited partners and select new investors.

Key Points: 
  • BOSTON, July 27, 2022 (GLOBE NEWSWIRE) -- Spectrum Equity , a leading growth equity firm, today announced the closing of Spectrum Equity X, L.P. ("Fund X") at a hard cap of $2 billion.Fund X was oversubscribed, receiving strong support from long-standing limited partners and select new investors.
  • Spectrum Equity provides capital and strategic support to internet-enabled software and data services companies across a range of industry verticals and has developed deep domain expertise and an established track record.
  • Consistent with Spectrum's prior funds, Fund X will invest in rapidly growing companies with scalable business models, persistent customer relationships, and emerging market leadership.
  • Spectrum Equity is a leading growth equity firm providing capital and strategic support to innovative companies in the information economy.

Zebra Technologies Completes Comprehensive Debt Refinancing

Retrieved on: 
Thursday, May 26, 2022

Zebra Technologies Corporation (NASDAQ: ZBRA), an innovator at the edge of the enterprise with solutions and partners that enable businesses to gain a performance edge, today announced actions to refinance its debt and expand liquidity.

Key Points: 
  • Zebra Technologies Corporation (NASDAQ: ZBRA), an innovator at the edge of the enterprise with solutions and partners that enable businesses to gain a performance edge, today announced actions to refinance its debt and expand liquidity.
  • Zebra may elect to update forward-looking statements but expressly disclaims any obligation to do so, even if the companys estimates change.
  • Follow Zebra's Your Edge blog , LinkedIn , Twitter and Facebook , and check out our Story Hub: Zebra Perspectives
    ZEBRA and the stylized Zebra head are trademarks of Zebra Technologies Corporation, registered in many jurisdictions worldwide.
  • 2022 Zebra Technologies Corporation and/or its affiliates.

Ten Coves Capital Closes Oversubscribed $293 Million Third Fund

Retrieved on: 
Wednesday, January 19, 2022

NEW YORK and DARIEN, Conn., Jan. 19, 2022 /PRNewswire/ -- Ten Coves Capital, LP ("Ten Coves"), a growth equity firm with an exclusive focus on investments in FinTech companies, announced today the closing of its third fund, Ten Coves Capital III, LP ("Fund III") with total commitments of $293 million.

Key Points: 
  • NEW YORK and DARIEN, Conn., Jan. 19, 2022 /PRNewswire/ -- Ten Coves Capital, LP ("Ten Coves"), a growth equity firm with an exclusive focus on investments in FinTech companies, announced today the closing of its third fund, Ten Coves Capital III, LP ("Fund III") with total commitments of $293 million.
  • Ten Coves Capital was formed in December 2020 in connection with the spinout of the growth equity team from Napier Park Global Capital, and included the assumption and management of the first two growth equity funds.
  • With Fund III, Ten Coves now manages more than $600 million in aggregate committed capital, and will continue its strategy of partnering with exceptional, rapidly growing companies across the FinTech ecosystem.
  • Forum Capital Securities LLC served as placement agent to Ten Coves and Proskauer served as legal counsel for Fund III.